Search for: "Bayer-Monsanto Company" Results 81 - 100 of 139
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Jul 2019, 9:21 am
While the company has been taken over by Bayer AG in 2018 and the formulation is also no-longer protected by patent, Roundup continues to be widely available to this day. [read post]
4 Jun 2021, 5:23 am by Miranda Goot
In February 2021, Bayer, the parent company of Monsanto, and court-appointed counsel for the proposed class proposed a settlement that would have provided diagnostic screening and payments to claimants who develop cancer, a four-year standstill on litigation, and a waiver of the right to seek punitive damages. [read post]
10 Jun 2021, 8:40 am
In 2020, Bayer, the company that owns Monsanto, the manufacturer of Roundup, agreed to pay over $10 billion to resolve a  large number of lawsuits. [read post]
22 Jan 2024, 6:59 am by omnizant.support
Bayer has defendant Roundup lawsuits claiming that the product is safe for its intended purpose and that the company did nothing wrong. [read post]
3 Jun 2016, 1:11 pm by Troy Ungerman
The most active companies were Monsanto (U.S.), Bayer AgroSciences (Germany) and Syngenta AG (Switzerland). [read post]
2 Jul 2020, 12:31 pm by Dean I. Weitzman, Esq.
The $10.9 billion fund was established by chemical and pharmaceutical giant Bayer, which has owned Roundup since acquiring Monsanto, the original makers of the product line, in June of 2018. [read post]
18 Aug 2010, 12:02 am by shellis
But in another case, Syngenta has received permission to combine cotton genes from Monsanto and Bayer. [read post]
1 May 2019, 9:02 pm by Dan Flynn
 Roundup is among the brands acquired by Bayer when the German company purchased St. [read post]
25 Jun 2014, 5:02 pm by Sabrina I. Pacifici
A report by Michele Simon and Friends of the Earth uncovers the deceptive public relations tactics chemical companies Bayer, Syngenta and Monsanto are using to manufacture doubt about science and fool politicians to delay action on neonicotinoid pesticides. [read post]
20 Jul 2018, 7:18 am by Todd Janzen
I saw very little presence from the giant crop-protection companies like Granular/Encirca, Climate Corporation/Monsanto/Bayer, or Syngenta. [read post]
17 Apr 2012, 4:30 am
Bayer Corp., 610 F.3d 390, 393 (7th Cir. 2010) and Tanoh v. [read post]
14 May 2014, 10:02 pm by Donald Sutherland
The majority of the world’s food seeds are owned by six companies: Monsanto, Bayer, Sygenta, BASF, DuPont and Dow. [read post]
28 Sep 2011, 1:56 am by Marie Louise
  Highlights this week included: US: CAFC: Patent exhaustion does not apply to genetically engineered seed: Monsanto Co. v. [read post]
24 Jan 2012, 4:22 pm by Lovechilde
BASF will be joining over 70 agricultural technology companies there, the Winston-Salem Journal reports, including Bayer CropScience and Syngenta. [read post]
28 Dec 2016, 7:00 am by Seemal Patel
Respondents also pointed to mega-deals such as the announcement of Microsoft’s US$28.1 billion acquisition of LinkedIn and Bayer AG’s US $63.4 billion bid for Monsanto Company as reasons to be optimistic. [read post]
30 Oct 2020, 10:28 am by Todd Janzen
The Climate Corporation became part of Monsanto/Bayer. [read post]
21 May 2008, 1:49 pm
BASF, Monsanto, Bayer, Syngenta, Dupont and biotech partners have filed 532 patent documents (a total of 55 patent families) on so-called “climate ready” genes at patent offices around the world. [read post]
26 Jan 2020, 11:05 pm
EPA; 1982: Monsanto and Calgene - a biotech company that Monsanto would later acquire - already working on creating Roundup crops - crops genetically modified to confer resistance to glyphosate; 1985: The U.S. [read post]
6 Oct 2010, 4:22 am by Kelly
(profitability through simplicity) US: Yeda Appeals Board decision favoring Abbott in TBP-II interference (Holman’s Biotech IP Blog) US: Jury finds Scruggs wilfully infringed Monsanto patents, awards at least $9 million in damages (Holman’s Biotech IP Blog) US: Marcy Kaptur’s bill to create a compulsory license for patented seeds: the Seed Availability and Competition Act of 2009 (KEI) US: Glaxosmithkline Biologicals seeks review of BPAI decision concerning isolated… [read post]